QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

white pills
A new QuintilesIMS Institute report explores the steady growth of drug expenditure in five developed countries, and what is driving these trends.
Claude Hughes
How innovations in maternal immunizations could save the lives of infants around the world and help WHO reach its Fourth Millennium Development Goal.
Read More
Rick Turner
Speaking on the benefits of CiPA at the European Society of Cardiology’s Annual Congress, in Barcelona.
Read More
Francine Nieto
How companies interested in the consumer health segment can tap into the demand for wellness products while navigating a changing marketplace
Read More
John Procter
Medical science liaisons provide a bridge between drug development and external stakeholders, meaning they are in an ideal situation to capture valuable scientific insights.
Read More
Forrest Anthony
FDA unanimously recommends approving this gene altering therapy for pediatric lymphoblastic leukemia.
Read More
Andy Tisman
How wellness trends and emerging markets growth are boosting sales in over-the-counter products.
Read More
Ray Huml
With patent expirations looming, biologic companies must innovate – or litigate – to protect their market share.
Read More
Sarah Rickwood
What it takes to thrive in an increasingly specialized marketplace.
Read More
Olga Uspenskaya-Cadoz
Tau imaging and predictive analytics take center stage at the annual event held by the Alzheimer’s Association.
Read More
Deep Patel
The growing need to treat and prevent AD is spurring new research, but healthcare industry stakeholders need to work collaboratively if we are going to successfully bring groundbreaking treatments to market.
Read More